Ketamine and Psychedelic Therapy in Billings, MT

How to Find Ketamine Care and a Psychedelic Therapist in Billings

The fastest way to find ketamine therapy near you in Billings is to decide between two paths: a guided at-home telehealth program, or an in-clinic provider you visit in person. Many people searching for a psychedelic therapist in Billings are really asking where they can legally start now, and the honest answer is ketamine, because it is the only psychedelic-class treatment that is legal and prescribable in Montana today.

With Mindbloom, the process starts with an online clinical evaluation. If ketamine therapy is a good fit for you, a licensed clinician prescribes a structured program you complete from home, with remote monitoring and a required peer treatment monitor present during sessions. A Billings resident can begin without driving across town or waiting for a local opening. If you prefer an in-person setting, Billings has a small number of ketamine and Spravato providers, and a local ketamine-assisted psychotherapy option, all covered in the comparison below.

Whichever path you choose, ketamine care is a prescription medical treatment, not a retail product. A licensed clinician confirms eligibility before treatment begins, which is a safeguard rather than a hurdle.

Ketamine and Psychedelic Therapy Near You Across the Billings Area

Because Mindbloom is delivered by telehealth, ketamine therapy is available anywhere in the Billings area, not just near the downtown medical corridor. Billings is Montana's largest city, and the at-home path means "ketamine therapy near me" resolves to your home rather than a specific clinic address.

The at-home program reaches Billings and Billings Heights, Laurel, Lockwood, Shepherd, and Worden, along with the surrounding Yellowstone County communities and the wider Billings metro across south-central Montana. In-clinic options cluster on the west side of Billings, so for the many patients who would otherwise drive in from rural towns, the at-home path is often the most practical way to access care close to home.

Your Ketamine and Psychedelic Therapy Options in Billings

There are a few real ways to get ketamine or psychedelic-class therapy in the Billings area. They differ in where treatment happens, the format, and cost. This comparison is by modality, since what matters is the type of care rather than one clinic versus another.

Many people arrive here searching for psychedelic therapy, thinking of psilocybin, MDMA, LSD, or ayahuasca. None of those are legally available for therapy in Montana: psilocybin and MDMA remain restricted, MDMA-assisted therapy is not FDA-approved or available, and the others are neither legal nor a Mindbloom service. That is exactly why ketamine is the psychedelic-class therapy you can legally start now in Billings, and with Mindbloom you do it from home. Even against psilocybin, Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ¹⁰

The at-home difference is what sets this apart: rather than repeated clinic visits, you get clinician-guided at-home ketamine therapy in Montana on a personalized schedule, at a lower per-session cost. You can also see how at-home ketamine compares with in-clinic IV, and full pricing for program details.

What Ketamine Therapy Can Help With

Depression is the flagship reason people begin ketamine therapy, and it is Mindbloom's primary indication. Ketamine treatment for depression is available across Billings via telehealth, and depression is where the evidence base is strongest.

Beyond depression, the programs also address anxiety, PTSD, grief, burnout, and sleep, each with tailored preparation and integration rather than a one-size prescription. PTSD is worth calling out for Montana's large veteran and first-responder population: Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes, and reports a 76.7% PTSD response rate in that study.¹ Conditions its evidence does not support, such as chronic pain, OCD, and addiction, are deliberately left off.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. The outcomes below draw on Mindbloom's peer-reviewed subcutaneous study, which covers depression, anxiety, and PTSD in one study¹, alongside two earlier peer-reviewed studies of its sublingual protocol⁵ ⁶ and research preprints extending the evidence to grief, burnout, and sleep. Together that is the largest published evidence base in at-home ketamine therapy. Individual results vary.

_{¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or 10 points (PCL-5); remission = final PHQ-9/GAD-7 below 5, or at least a 10-point reduction and PCL-5 below 33. ² Swain et al. 2026 (grief, PGD-13), n=503. ³ Swain et al. (burnout, MBI-GS), n=395. ⁴ Swain et al. 2026 (sleep, PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0).}

Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How those outcomes compare with other treatments, each a study-to-study comparison:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs ~41%), and reached faster.¹ ⁷
• Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety (60.6% vs 47%), in about half the time.¹ ⁸
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time (76% response, within its 66 to 82% range, reached in about 6 sessions versus 16).² ⁹

Is Ketamine or Psychedelic Therapy Legal in Montana?

Yes for ketamine. Ketamine is legal, FDA-approved as a Schedule III medication, prescribable by a licensed clinician, and available now via telehealth in Billings. That is what makes at-home treatment with Mindbloom possible statewide.

Psilocybin and MDMA are a different story. Neither is legal for therapy in Montana. Psilocybin is a Schedule I controlled substance under state law¹², a 2023 bill to create a licensed therapeutic-psilocybin program did not pass, and no Montana city has decriminalized psychedelics. MDMA-assisted therapy is not FDA-approved or available anywhere in the country. So as of now there is no licensed psilocybin or MDMA therapy in Billings, and ketamine remains the psychedelic-class therapy you can legally begin today.

How At-Home Ketamine Therapy Works

The path is straightforward. You complete an online clinical evaluation, and a licensed clinician reviews your history and decides whether ketamine therapy is appropriate. If it is a good fit, they prescribe a program and your treatment ships to you along with the supportive materials you need.

Sessions happen at home on a clinician-guided schedule, with a required peer treatment monitor present, guided preparation beforehand, and integration afterward to help the experience translate into lasting change. Many people feel meaningful relief early in the program, with benefits building cumulatively across the full course rather than arriving all at once.

Safety, Candidacy, and Cost

Ketamine therapy has a well-characterized safety profile in Mindbloom's published data, with serious adverse events occurring in fewer than 0.1% of participants across its studies. It is not right for everyone, which is why every client starts with a clinical evaluation and a licensed clinician confirms eligibility before treatment begins.

On cost, Mindbloom's programs run $165 to $215 per session depending on program length, structured as 6, 12, or 18 sessions and paid out of pocket, with HSA and FSA funds accepted and possible out-of-network reimbursement. Billings clinics do not publish set IV pricing, and in-clinic IV ketamine typically runs higher, roughly $350 to $650 or more per session.¹³ Spravato, an in-clinic option, may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket. The program is also built to work alongside your existing care, so you can keep your current therapist while adding ketamine therapy. If you want to see whether it is a fit, eligibility begins with an online clinician evaluation.